Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

Detalles Bibliográficos
Autores principales: Hunault-Berger, M, Maillard, N, Himberlin, C, Recher, C, Schmidt-Tanguy, A, Choufi, B, Bonmati, C, Carré, M, Couturier, M-A, Daguindau, E, Marolleau, J-P, Orsini-Piocelle, F, Delaunay, J, Tavernier, E, Lissandre, S, Ojeda-Uribe, M, Sanhes, L, Sutton, L, Banos, A, Fornecker, L M, Bernard, M, Bouscary, D, Saad, A, Puyade, M, Rouillé, V, Luquet, I, Béné, M C, Hamel, J-F, Dreyfus, F, Ifrah, N, Pigneux, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520397/
https://www.ncbi.nlm.nih.gov/pubmed/28574488
http://dx.doi.org/10.1038/bcj.2017.50
_version_ 1783251812240850944
author Hunault-Berger, M
Maillard, N
Himberlin, C
Recher, C
Schmidt-Tanguy, A
Choufi, B
Bonmati, C
Carré, M
Couturier, M-A
Daguindau, E
Marolleau, J-P
Orsini-Piocelle, F
Delaunay, J
Tavernier, E
Lissandre, S
Ojeda-Uribe, M
Sanhes, L
Sutton, L
Banos, A
Fornecker, L M
Bernard, M
Bouscary, D
Saad, A
Puyade, M
Rouillé, V
Luquet, I
Béné, M C
Hamel, J-F
Dreyfus, F
Ifrah, N
Pigneux, A
author_facet Hunault-Berger, M
Maillard, N
Himberlin, C
Recher, C
Schmidt-Tanguy, A
Choufi, B
Bonmati, C
Carré, M
Couturier, M-A
Daguindau, E
Marolleau, J-P
Orsini-Piocelle, F
Delaunay, J
Tavernier, E
Lissandre, S
Ojeda-Uribe, M
Sanhes, L
Sutton, L
Banos, A
Fornecker, L M
Bernard, M
Bouscary, D
Saad, A
Puyade, M
Rouillé, V
Luquet, I
Béné, M C
Hamel, J-F
Dreyfus, F
Ifrah, N
Pigneux, A
author_sort Hunault-Berger, M
collection PubMed
description
format Online
Article
Text
id pubmed-5520397
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-55203972017-07-26 Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial Hunault-Berger, M Maillard, N Himberlin, C Recher, C Schmidt-Tanguy, A Choufi, B Bonmati, C Carré, M Couturier, M-A Daguindau, E Marolleau, J-P Orsini-Piocelle, F Delaunay, J Tavernier, E Lissandre, S Ojeda-Uribe, M Sanhes, L Sutton, L Banos, A Fornecker, L M Bernard, M Bouscary, D Saad, A Puyade, M Rouillé, V Luquet, I Béné, M C Hamel, J-F Dreyfus, F Ifrah, N Pigneux, A Blood Cancer J Letter to the Editor Nature Publishing Group 2017-06 2017-06-02 /pmc/articles/PMC5520397/ /pubmed/28574488 http://dx.doi.org/10.1038/bcj.2017.50 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Letter to the Editor
Hunault-Berger, M
Maillard, N
Himberlin, C
Recher, C
Schmidt-Tanguy, A
Choufi, B
Bonmati, C
Carré, M
Couturier, M-A
Daguindau, E
Marolleau, J-P
Orsini-Piocelle, F
Delaunay, J
Tavernier, E
Lissandre, S
Ojeda-Uribe, M
Sanhes, L
Sutton, L
Banos, A
Fornecker, L M
Bernard, M
Bouscary, D
Saad, A
Puyade, M
Rouillé, V
Luquet, I
Béné, M C
Hamel, J-F
Dreyfus, F
Ifrah, N
Pigneux, A
Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
title Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
title_full Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
title_fullStr Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
title_full_unstemmed Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
title_short Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
title_sort maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase ii multicentre filo trial
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520397/
https://www.ncbi.nlm.nih.gov/pubmed/28574488
http://dx.doi.org/10.1038/bcj.2017.50
work_keys_str_mv AT hunaultbergerm maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT maillardn maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT himberlinc maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT recherc maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT schmidttanguya maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT choufib maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT bonmatic maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT carrem maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT couturierma maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT daguindaue maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT marolleaujp maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT orsinipiocellef maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT delaunayj maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT taverniere maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT lissandres maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT ojedauribem maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT sanhesl maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT suttonl maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT banosa maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT forneckerlm maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT bernardm maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT bouscaryd maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT saada maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT puyadem maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT rouillev maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT luqueti maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT benemc maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT hameljf maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT dreyfusf maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT ifrahn maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial
AT pigneuxa maintenancetherapywithalternatingazacitidineandlenalidomideinelderlyfitpatientswithpoorprognosisacutemyeloidleukemiaaphaseiimulticentrefilotrial

Ejemplares similares